286 related articles for article (PubMed ID: 32046221)
1. Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species.
Solnier J; Martin L; Bhakta S; Bucar F
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046221
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial and Efflux Pump Inhibitory Activity of Carvotacetones from
Tran HT; Solnier J; Pferschy-Wenzig EM; Kunert O; Martin L; Bhakta S; Huynh L; Le TM; Bauer R; Bucar F
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32650510
[TBL] [Abstract][Full Text] [Related]
3. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.
Lechner D; Gibbons S; Bucar F
J Antimicrob Chemother; 2008 Aug; 62(2):345-8. PubMed ID: 18430720
[TBL] [Abstract][Full Text] [Related]
4. Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistance.
Rodrigues L; Ramos J; Couto I; Amaral L; Viveiros M
BMC Microbiol; 2011 Feb; 11():35. PubMed ID: 21332993
[TBL] [Abstract][Full Text] [Related]
5. Farnesol, a potential efflux pump inhibitor in Mycobacterium smegmatis.
Jin J; Zhang JY; Guo N; Sheng H; Li L; Liang JC; Wang XL; Li Y; Liu MY; Wu XP; Yu L
Molecules; 2010 Oct; 15(11):7750-62. PubMed ID: 21042264
[TBL] [Abstract][Full Text] [Related]
6. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis.
Rai D; Mehra S
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0026221. PubMed ID: 34424047
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
Piddock LJ; Williams KJ; Ricci V
J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
[TBL] [Abstract][Full Text] [Related]
8. Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
Gröblacher B; Maier V; Kunert O; Bucar F
J Nat Prod; 2012 Jul; 75(7):1393-9. PubMed ID: 22789014
[TBL] [Abstract][Full Text] [Related]
9. Measuring Efflux and Permeability in Mycobacteria.
Rodrigues L; Aínsa JA; Viveiros M
Methods Mol Biol; 2021; 2314():231-245. PubMed ID: 34235655
[TBL] [Abstract][Full Text] [Related]
10. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis.
Rodrigues L; Wagner D; Viveiros M; Sampaio D; Couto I; Vavra M; Kern WV; Amaral L
J Antimicrob Chemother; 2008 May; 61(5):1076-82. PubMed ID: 18310137
[TBL] [Abstract][Full Text] [Related]
11. Resistance modulatory and efflux-inhibitory activities of capsaicinoids and capsinoids.
Prasch S; Duran AG; Chinchilla N; Molinillo JMG; Macías FA; Bucar F
Bioorg Chem; 2019 Feb; 82():378-384. PubMed ID: 30428416
[TBL] [Abstract][Full Text] [Related]
12. Bacterial efflux inhibitors are widely distributed in land plants.
Brown AR; Ettefagh KA; Todd DA; Cole PS; Egan JM; Foil DH; Lacey EP; Cech NB
J Ethnopharmacol; 2021 Mar; 267():113533. PubMed ID: 33137433
[TBL] [Abstract][Full Text] [Related]
13. Measuring efflux and permeability in mycobacteria.
Rodrigues L; Viveiros M; Aínsa JA
Methods Mol Biol; 2015; 1285():227-39. PubMed ID: 25779319
[TBL] [Abstract][Full Text] [Related]
14. Efflux Pump Inhibition and Resistance Modulation in
Šimunović K; Solnier J; Alperth F; Kunert O; Smole Možina S; Bucar F
Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572657
[TBL] [Abstract][Full Text] [Related]
15. Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria.
Padwal P; Bandyopadhyaya R; Mehra S
Langmuir; 2014 Dec; 30(50):15266-76. PubMed ID: 25375643
[TBL] [Abstract][Full Text] [Related]
16. The plant alkaloid piperine as a potential inhibitor of ethidium bromide efflux in Mycobacterium smegmatis.
Jin J; Zhang J; Guo N; Feng H; Li L; Liang J; Sun K; Wu X; Wang X; Liu M; Deng X; Yu L
J Med Microbiol; 2011 Feb; 60(Pt 2):223-229. PubMed ID: 21051548
[TBL] [Abstract][Full Text] [Related]
17. Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants.
Felicetti T; Machado D; Cannalire R; Astolfi A; Massari S; Tabarrini O; Manfroni G; Barreca ML; Cecchetti V; Viveiros M; Sabatini S
ACS Infect Dis; 2019 Jun; 5(6):982-1000. PubMed ID: 30907573
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636.
Bhowruth V; Brown AK; Besra GS
Microbiology (Reading); 2008 Jul; 154(Pt 7):1866-1875. PubMed ID: 18599816
[TBL] [Abstract][Full Text] [Related]
19. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.
Li XZ; Zhang L; Nikaido H
Antimicrob Agents Chemother; 2004 Jul; 48(7):2415-23. PubMed ID: 15215089
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of Novel Hybrid Efflux Pump Inhibitors for Use against Mycobacterium tuberculosis.
Kumar M; Singh K; Naran K; Hamzabegovic F; Hoft DF; Warner DF; Ruminski P; Abate G; Chibale K
ACS Infect Dis; 2016 Oct; 2(10):714-725. PubMed ID: 27737555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
